One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study
ConclusionThis first French real-world study related to migraine prevention with CGRP-mAbs confirms effectiveness and safety of erenumab in patients with extreme unmet needs.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Alopecia | Chronic Pain | Clinical Trials | Constipation | France Health | Headache | Migraine | Neurology | Pain | Pregnancy | Study